Skip to main content
Journal cover image

Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.

Publication ,  Journal Article
Hassan, R; Alexander, R; Antman, K; Boffetta, P; Churg, A; Coit, D; Hausner, P; Kennedy, R; Kindler, H; Metintas, M; Mutti, L; Onda, M ...
Published in: Ann Oncol
November 2006

Peritoneal mesothelioma is a rare cancer of the peritoneum with about 250 new cases diagnosed each year in the United States. It is the second most common site for mesothelioma development and accounts for 10-20% of all mesotheliomas diagnosed in the United States. A meeting sponsored by the NIH Office of Rare Diseases was held in Bethesda, Maryland on September 13 and 14, 2004. The objective of this meeting was to review the epidemiology, biology and current surgical and medical management of peritoneal mesothelioma. In addition, the meeting also discussed clinical and pre-clinical evaluation of novel treatments for mesothelioma as well as ongoing laboratory research to better understand this disease. This report summarizes the proceedings of the meeting as well as directions for future clinical and basic research.

Duke Scholars

Published In

Ann Oncol

DOI

ISSN

0923-7534

Publication Date

November 2006

Volume

17

Issue

11

Start / End Page

1615 / 1619

Location

England

Related Subject Headings

  • United States
  • Peritoneal Neoplasms
  • Oncology & Carcinogenesis
  • National Institutes of Health (U.S.)
  • Mesothelioma
  • Humans
  • Drug Evaluation, Preclinical
  • Clinical Trials as Topic
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Hassan, R., Alexander, R., Antman, K., Boffetta, P., Churg, A., Coit, D., … Verschraegen, C. (2006). Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol, 17(11), 1615–1619. https://doi.org/10.1093/annonc/mdl060
Hassan, R., R. Alexander, K. Antman, P. Boffetta, A. Churg, D. Coit, P. Hausner, et al. “Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.Ann Oncol 17, no. 11 (November 2006): 1615–19. https://doi.org/10.1093/annonc/mdl060.
Hassan R, Alexander R, Antman K, Boffetta P, Churg A, Coit D, et al. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006 Nov;17(11):1615–9.
Hassan, R., et al. “Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.Ann Oncol, vol. 17, no. 11, Nov. 2006, pp. 1615–19. Pubmed, doi:10.1093/annonc/mdl060.
Hassan R, Alexander R, Antman K, Boffetta P, Churg A, Coit D, Hausner P, Kennedy R, Kindler H, Metintas M, Mutti L, Onda M, Pass H, Premkumar A, Roggli V, Sterman D, Sugarbaker P, Taub R, Verschraegen C. Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference. Ann Oncol. 2006 Nov;17(11):1615–1619.
Journal cover image

Published In

Ann Oncol

DOI

ISSN

0923-7534

Publication Date

November 2006

Volume

17

Issue

11

Start / End Page

1615 / 1619

Location

England

Related Subject Headings

  • United States
  • Peritoneal Neoplasms
  • Oncology & Carcinogenesis
  • National Institutes of Health (U.S.)
  • Mesothelioma
  • Humans
  • Drug Evaluation, Preclinical
  • Clinical Trials as Topic
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences